(+)-dexrazoxane decreases expression ISO RGD:10392 6480464 Dexrazoxane results in decreased expression of CPT2 mRNA CTD PMID:26873546 (+)-dexrazoxane multiple interactions ISO RGD:10392 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of CPT2 mRNA CTD PMID:26873546 (R)-carnitine multiple interactions ISO RGD:736835 6480464 Carnitine promotes the reaction [[Bezafibrate results in increased activity of CPT2 protein] which results in increased abundance of Adenosine Triphosphate] CTD PMID:21816645 (S)-colchicine decreases expression ISO RGD:736835 6480464 Colchicine results in decreased expression of CPT2 mRNA CTD PMID:24211769 1,1-dichloroethene decreases expression ISO RGD:10392 6480464 vinylidene chloride results in decreased expression of CPT2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:10392 6480464 1, 2-Dimethylhydrazine results in decreased expression of CPT2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:10392 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CPT2 mRNA CTD PMID:22206623 1,4-benzoquinone decreases expression ISO RGD:736835 6480464 quinone results in decreased expression of CPT2 mRNA CTD PMID:32478940 1-naphthyl isothiocyanate multiple interactions ISO RGD:10392 6480464 Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CPT2 mRNA] CTD PMID:33749747 1-naphthyl isothiocyanate decreases expression ISO RGD:10392 6480464 1-Naphthylisothiocyanate results in decreased expression of CPT2 mRNA CTD PMID:33749747 17alpha-ethynylestradiol increases expression ISO RGD:10392 6480464 Ethinyl Estradiol results in increased expression of CPT2 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:736835 6480464 Estradiol results in decreased expression of CPT2 mRNA CTD PMID:20106945 17beta-estradiol multiple interactions ISO RGD:736835 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CPT2 mRNA CTD PMID:30165855 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10392 6480464 [Dietary Fats co-treated with 2 more ... CTD PMID:23618531 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of CPT2 protein] CTD PMID:21136691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10392 6480464 Tetrachlorodibenzodioxin results in increased expression of CPT2 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10392 6480464 Tetrachlorodibenzodioxin affects the expression of CPT2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CPT2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CPT2 mRNA CTD PMID:22298810 2,4,6-tribromophenol decreases expression ISO RGD:736835 6480464 2 more ... CTD PMID:31675489 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CPT2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:736835 6480464 Lactic Acid results in decreased expression of CPT2 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:736835 6480464 tetrabromobisphenol A results in increased expression of CPT2 protein CTD PMID:31675489 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of CPT2 mRNA CTD PMID:30071829 3,5-diethoxycarbonyl-1,4-dihydrocollidine decreases expression ISO RGD:10392 6480464 3 more ... CTD PMID:20512997 3-chloropropane-1,2-diol affects expression EXP 6480464 alpha-Chlorohydrin analog affects the expression of CPT2 protein CTD PMID:26597043 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:10392 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CPT2 mRNA CTD PMID:23428407 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases expression ISO RGD:736835 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO RGD:736835 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CPT2 mRNA CTD PMID:31881176 adenine decreases expression ISO RGD:736835 6480464 Adenine results in decreased expression of CPT2 mRNA CTD PMID:24211769 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CPT2 mRNA CTD PMID:33354967 aldehydo-D-glucose affects expression EXP 6480464 Glucose affects the expression of CPT2 mRNA CTD PMID:24349266 all-trans-retinoic acid increases expression ISO RGD:736835 6480464 Tretinoin results in increased expression of CPT2 mRNA CTD PMID:33167477 allopurinol multiple interactions ISO RGD:10392 6480464 Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CPT2 mRNA] CTD PMID:33749747 amiodarone increases expression ISO RGD:10392 6480464 Amiodarone results in increased expression of CPT2 mRNA CTD PMID:24489787 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CPT2 mRNA CTD PMID:16483693 aristolochic acid decreases expression ISO RGD:10392 6480464 aristolochic acid I results in decreased expression of CPT2 mRNA CTD PMID:31009690 ATP multiple interactions ISO RGD:736835 6480464 [Bezafibrate results in increased activity of CPT2 protein] which results in increased abundance of Adenosine Triphosphate, Carnitine promotes the reaction [[Bezafibrate results in increased activity of CPT2 protein] which results in increased abundance of Adenosine Triphosphate] CTD PMID:21816645 atrazine decreases expression ISO RGD:736835 6480464 Atrazine results in decreased expression of CPT2 mRNA CTD PMID:22378314 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA CTD PMID:33854195 benzo[a]pyrene increases expression ISO RGD:736835 6480464 Benzo(a)pyrene results in increased expression of CPT2 protein CTD PMID:32717239 benzo[a]pyrene decreases methylation ISO RGD:10392 6480464 Benzo(a)pyrene results in decreased methylation of CPT2 exon CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:736835 6480464 Benzo(a)pyrene results in decreased methylation of CPT2 promoter CTD PMID:27901495 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of CPT2 mRNA CTD PMID:16648578 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of CPT2 mRNA CTD PMID:16707586 bezafibrate increases expression ISO RGD:736835 6480464 Bezafibrate results in increased expression of CPT2 mRNA CTD PMID:21816645 bezafibrate multiple interactions ISO RGD:736835 6480464 [Bezafibrate results in increased activity of CPT2 protein] which results in increased abundance of Adenosine Triphosphate more ... CTD PMID:21816645 , PMID:24534255 bezafibrate increases activity ISO RGD:736835 6480464 Bezafibrate results in increased activity of CPT2 protein CTD PMID:21816645 bis(2-ethylhexyl) phthalate increases expression ISO RGD:10392 6480464 Diethylhexyl Phthalate results in increased expression of CPT2 mRNA CTD PMID:19245819 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Dietary Fats] results in increased expression of CPT2 mRNA CTD PMID:33166671 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CPT2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:736835 6480464 bisphenol A results in decreased expression of CPT2 protein CTD PMID:31675489 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CPT2 mRNA CTD PMID:34947998 bisphenol A decreases expression ISO RGD:10392 6480464 bisphenol A results in decreased expression of CPT2 mRNA CTD PMID:27502578 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of CPT2 protein CTD PMID:28903499 buspirone increases expression EXP 6480464 Buspirone results in increased expression of CPT2 mRNA CTD PMID:24136188 cadmium atom increases oxidation ISO RGD:10392 6480464 Cadmium results in increased oxidation of CPT2 protein CTD PMID:24496640 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CPT2 protein CTD PMID:21699967 carbamazepine affects expression ISO RGD:736835 6480464 Carbamazepine affects the expression of CPT2 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:10392 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbon nanotube decreases expression ISO RGD:10392 6480464 Nanotubes, Carbon results in decreased expression of CPT2 mRNA CTD PMID:32976959 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA CTD PMID:33854195 ciprofibrate increases expression EXP 6480464 ciprofibrate results in increased expression of CPT2 mRNA CTD PMID:27225895 ciprofibrate increases expression ISO RGD:10392 6480464 ciprofibrate results in increased expression of CPT2 mRNA CTD PMID:27225895 cisplatin decreases expression ISO RGD:736835 6480464 Cisplatin results in decreased expression of CPT2 mRNA CTD PMID:24211769 cisplatin increases expression ISO RGD:736835 6480464 Cisplatin results in increased expression of CPT2 mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:10392 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CPT2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CPT2 mRNA] CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of CPT2 protein CTD PMID:20118634 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CPT2 mRNA, Clofibrate results in increased expression of CPT2 protein CTD PMID:11328961 more ... clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of CPT2 mRNA CTD PMID:17602206 clozapine multiple interactions EXP 6480464 [Clozapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased activity of CPT2 protein, [Clozapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased expression of CPT2 mRNA CTD PMID:23226405 copper(II) sulfate decreases expression ISO RGD:736835 6480464 Copper Sulfate results in decreased expression of CPT2 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:736835 6480464 Cyclosporine results in decreased expression of CPT2 mRNA CTD PMID:20106945 , PMID:25562108 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CPT2 mRNA CTD PMID:29038839 D-glucose affects expression EXP 6480464 Glucose affects the expression of CPT2 mRNA CTD PMID:24349266 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of CPT2 mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO RGD:10392 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CPT2 mRNA CTD PMID:23428407 dibutyl phthalate decreases expression ISO RGD:10392 6480464 Dibutyl Phthalate results in decreased expression of CPT2 mRNA CTD PMID:17361019 , PMID:21266533 dichloroacetic acid increases expression ISO RGD:10392 6480464 Dichloroacetic Acid results in increased expression of CPT2 mRNA CTD PMID:28962523 Diosbulbin B decreases expression ISO RGD:10392 6480464 diosbulbin B results in decreased expression of CPT2 mRNA CTD PMID:32148032 dipentyl phthalate increases expression EXP 6480464 di-n-pentyl phthalate results in increased expression of CPT2 mRNA CTD PMID:33983380 diuron increases expression EXP 6480464 Diuron results in increased expression of CPT2 mRNA CTD PMID:21551480 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CPT2 mRNA CTD PMID:19915844 doxorubicin decreases expression ISO RGD:736835 6480464 Doxorubicin results in decreased expression of CPT2 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:10392 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of CPT2 mRNA CTD PMID:26873546 doxorubicin decreases expression ISO RGD:10392 6480464 Doxorubicin results in decreased expression of CPT2 mRNA CTD PMID:26873546 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CPT2 mRNA CTD PMID:29038839 ethanol multiple interactions ISO RGD:736835 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CPT2 mRNA CTD PMID:29432896 ethyl methanesulfonate decreases expression ISO RGD:736835 6480464 Ethyl Methanesulfonate results in decreased expression of CPT2 mRNA CTD PMID:24211769 etoposide decreases expression ISO RGD:736835 6480464 Etoposide results in decreased expression of CPT2 mRNA CTD PMID:24211769 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of CPT2 protein CTD PMID:20118634 fenofibrate multiple interactions ISO RGD:10392 6480464 Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of CPT2 mRNA] CTD PMID:28871336 fenofibrate increases expression ISO RGD:736835 6480464 Fenofibrate results in increased expression of CPT2 mRNA CTD PMID:25572481 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of CPT2 mRNA CTD PMID:16595124 more ... fenofibrate multiple interactions ISO RGD:736835 6480464 [Oleic Acid co-treated with Fenofibrate] results in increased expression of CPT2 mRNA CTD PMID:24534255 finasteride increases expression EXP 6480464 Finasteride results in increased expression of CPT2 mRNA CTD PMID:24136188 fluoranthene multiple interactions ISO RGD:10392 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CPT2 mRNA CTD PMID:28329830 flutamide decreases expression ISO RGD:10392 6480464 Flutamide results in decreased expression of CPT2 mRNA CTD PMID:17702527 folic acid multiple interactions ISO RGD:10392 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CPT2 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:736835 6480464 Formaldehyde results in increased expression of CPT2 mRNA CTD PMID:23649840 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of CPT2 mRNA CTD PMID:27665778 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CPT2 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CPT2 mRNA CTD PMID:24136188 glucose affects expression EXP 6480464 Glucose affects the expression of CPT2 mRNA CTD PMID:24349266 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA CTD PMID:33854195 gold atom multiple interactions ISO RGD:736835 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of CPT2 mRNA CTD PMID:28433809 gold(0) multiple interactions ISO RGD:736835 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of CPT2 mRNA CTD PMID:28433809 GW 4064 multiple interactions ISO RGD:736835 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of CPT2 mRNA CTD PMID:30611723 GW 7647 multiple interactions ISO RGD:736835 6480464 [GW 7647 co-treated with Oleic Acid] results in increased expression of CPT2 mRNA CTD PMID:30611723 GW 7647 increases expression ISO RGD:736835 6480464 GW 7647 results in increased expression of CPT2 mRNA CTD PMID:30611723 hydrazine increases expression ISO RGD:10392 6480464 hydrazine results in increased expression of CPT2 mRNA CTD PMID:15282401 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of CPT2 mRNA CTD PMID:24349266 hydroxyurea decreases expression ISO RGD:736835 6480464 Hydroxyurea results in decreased expression of CPT2 mRNA CTD PMID:24211769 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA CTD PMID:33854195 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of CPT2 mRNA more ... CTD PMID:25045214 , PMID:30303030 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of CPT2 mRNA CTD PMID:25045214 isotretinoin decreases expression ISO RGD:736835 6480464 Isotretinoin results in decreased expression of CPT2 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:736835 6480464 Ivermectin results in decreased expression of CPT2 protein CTD PMID:32959892 lead(0) affects expression ISO RGD:736835 6480464 Lead affects the expression of CPT2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:736835 6480464 Lead affects the expression of CPT2 mRNA CTD PMID:28903495 leflunomide decreases expression ISO RGD:736835 6480464 leflunomide results in decreased expression of CPT2 mRNA CTD PMID:28988120 , PMID:29427785 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CPT2 mRNA CTD PMID:24136188 lithocholic acid decreases expression ISO RGD:10392 6480464 Lithocholic Acid results in decreased expression of CPT2 mRNA CTD PMID:20359477 methyl methanesulfonate increases expression ISO RGD:736835 6480464 Methyl Methanesulfonate results in increased expression of CPT2 mRNA CTD PMID:23649840 methyl methanesulfonate decreases expression ISO RGD:736835 6480464 Methyl Methanesulfonate results in decreased expression of CPT2 mRNA CTD PMID:24211769 mitomycin C decreases expression ISO RGD:736835 6480464 Mitomycin results in decreased expression of CPT2 mRNA CTD PMID:24211769 mono(2-ethylhexyl) phthalate increases expression ISO RGD:10392 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CPT2 mRNA CTD PMID:32522588 monosodium L-glutamate multiple interactions ISO RGD:10392 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CPT2 mRNA CTD PMID:19001666 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CPT2 mRNA CTD PMID:21515302 Muraglitazar multiple interactions ISO RGD:736835 6480464 [muraglitazar co-treated with Oleic Acid] results in increased expression of CPT2 mRNA CTD PMID:24534255 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of CPT2 mRNA CTD PMID:24136188 nicotinic acid decreases expression ISO RGD:736835 6480464 Niacin results in decreased expression of CPT2 mRNA CTD PMID:19131065 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of CPT2 mRNA CTD PMID:24136188 obeticholic acid increases expression ISO RGD:736835 6480464 obeticholic acid results in increased expression of CPT2 mRNA CTD PMID:27939613 olanzapine multiple interactions EXP 6480464 [olanzapine co-treated with 1-(carboxymethylthio)tetradecane] results in decreased expression of CPT2 mRNA more ... CTD PMID:23226405 oleic acid multiple interactions ISO RGD:736835 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:24534255 , PMID:30611723 orlistat decreases expression ISO RGD:736835 6480464 Orlistat results in decreased expression of CPT2 protein CTD PMID:30667213 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of CPT2 mRNA CTD PMID:30316929 ozone increases expression EXP 6480464 Ozone results in increased expression of CPT2 mRNA CTD PMID:33217375 , PMID:33524448 paclitaxel decreases expression ISO RGD:736835 6480464 Paclitaxel results in decreased expression of CPT2 protein CTD PMID:30667213 paracetamol multiple interactions ISO RGD:10392 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CPT2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CPT2 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CPT2 mRNA CTD PMID:32479839 paracetamol decreases expression ISO RGD:736835 6480464 Acetaminophen results in decreased expression of CPT2 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression ISO RGD:10392 6480464 Acetaminophen affects the expression of CPT2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:10392 6480464 Acetaminophen results in decreased expression of CPT2 mRNA CTD PMID:17585979 perfluorohexanesulfonic acid increases expression ISO RGD:10392 6480464 perfluorohexanesulfonic acid results in increased expression of CPT2 mRNA CTD PMID:28558994 perfluorononanoic acid increases expression ISO RGD:10392 6480464 perfluoro-n-nonanoic acid results in increased expression of CPT2 mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid affects expression ISO RGD:10392 6480464 perfluorooctane sulfonic acid affects the expression of CPT2 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid increases expression ISO RGD:10392 6480464 perfluorooctane sulfonic acid results in increased expression of CPT2 mRNA CTD PMID:20936131 more ... perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CPT2 mRNA CTD PMID:18692542 perfluorooctanoic acid affects expression ISO RGD:10392 6480464 perfluorooctanoic acid affects the expression of CPT2 mRNA CTD PMID:19429403 perfluorooctanoic acid increases expression ISO RGD:736835 6480464 perfluorooctanoic acid results in increased expression of CPT2 mRNA CTD PMID:23978341 more ... perfluorooctanoic acid increases expression ISO RGD:10392 6480464 perfluorooctanoic acid results in increased expression of CPT2 mRNA CTD PMID:18467677 more ... perfluorooctanoic acid multiple interactions ISO RGD:10392 6480464 Dietary Fats more ... CTD PMID:18467677 more ... perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CPT2 mRNA CTD PMID:16221955 more ... phenobarbital affects expression ISO RGD:736835 6480464 Phenobarbital affects the expression of CPT2 mRNA CTD PMID:19159669 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CPT2 mRNA CTD PMID:27225895 phlorizin decreases expression ISO RGD:10392 6480464 Phlorhizin results in decreased expression of CPT2 mRNA CTD PMID:22538082 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of CPT2 mRNA CTD PMID:22484513 pirinixic acid multiple interactions ISO RGD:10392 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of CPT2 mRNA] CTD PMID:17950772 pirinixic acid increases expression ISO RGD:736835 6480464 pirinixic acid results in increased expression of CPT2 mRNA CTD PMID:27551952 pirinixic acid increases expression ISO RGD:10392 6480464 pirinixic acid results in increased expression of CPT2 mRNA CTD PMID:15375163 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CPT2 mRNA CTD PMID:16707586 more ... potassium chloride multiple interactions ISO RGD:736835 6480464 [Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of CPT2 mRNA CTD PMID:29691375 pravastatin decreases expression ISO RGD:10392 6480464 Pravastatin results in decreased expression of CPT2 mRNA CTD PMID:27225895 prochloraz multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CPT2 mRNA CTD PMID:29038839 quercetin decreases expression ISO RGD:736835 6480464 Quercetin results in decreased expression of CPT2 mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:736835 6480464 Lactic Acid results in decreased expression of CPT2 mRNA CTD PMID:30851411 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CPT2 mRNA CTD PMID:28374803 sirolimus multiple interactions EXP 6480464 Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT2 mRNA], TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of CPT2 mRNA]] CTD PMID:25045214 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CPT2 mRNA, sodium arsenite results in increased expression of CPT2 protein CTD PMID:25697676 , PMID:29459688 sodium arsenite increases expression ISO RGD:736835 6480464 sodium arsenite results in increased expression of CPT2 mRNA CTD PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of CPT2 mRNA CTD PMID:19281266 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CPT2 protein CTD PMID:21136691 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of CPT2 protein] CTD PMID:21136691 sulforaphane increases expression ISO RGD:10392 6480464 sulforaphane results in increased expression of CPT2 mRNA CTD PMID:30529165 sunitinib decreases expression ISO RGD:736835 6480464 Sunitinib results in decreased expression of CPT2 mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:736835 6480464 Temozolomide results in increased expression of CPT2 mRNA CTD PMID:31758290 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CPT2 mRNA CTD PMID:21515302 Tesaglitazar multiple interactions ISO RGD:736835 6480464 [Oleic Acid co-treated with tesaglitazar] results in increased expression of CPT2 mRNA CTD PMID:24534255 tetrachloromethane decreases expression ISO RGD:10392 6480464 Carbon Tetrachloride results in decreased expression of CPT2 mRNA CTD PMID:31919559 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA CTD PMID:33854195 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CPT2 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:10392 6480464 titanium dioxide results in decreased expression of CPT2 mRNA CTD PMID:23557971 tributyl phosphate increases expression ISO RGD:736835 6480464 tributyl phosphate results in increased expression of CPT2 mRNA CTD PMID:30966736 tributylstannane increases expression ISO RGD:10392 6480464 tributyltin results in increased expression of CPT2 mRNA CTD PMID:23428407 trichloroacetic acid increases expression ISO RGD:10392 6480464 Trichloroacetic Acid results in increased expression of CPT2 mRNA CTD PMID:23575800 trichloroethene increases expression ISO RGD:10392 6480464 Trichloroethylene results in increased expression of CPT2 mRNA CTD PMID:19448997 triphenyl phosphate increases expression ISO RGD:736835 6480464 triphenyl phosphate results in increased expression of CPT2 mRNA CTD PMID:30966736 Triptolide decreases expression ISO RGD:10392 6480464 triptolide results in decreased expression of CPT2 mRNA CTD PMID:31241159 triptonide increases expression ISO RGD:10392 6480464 triptonide results in increased expression of CPT2 mRNA CTD PMID:33045310 Tris(2,3-dibromopropyl) phosphate increases expression ISO RGD:736835 6480464 tris(2, 3-dibromopropyl)phosphate results in increased expression of CPT2 mRNA CTD PMID:30966736 tris(2-butoxyethyl) phosphate decreases expression ISO RGD:736835 6480464 tris(2-butoxyethyl) phosphate results in decreased expression of CPT2 mRNA CTD PMID:30966736 Tris(2-ethylhexyl) phosphate increases expression ISO RGD:736835 6480464 tris(2-ethylhexyl)phosphate results in increased expression of CPT2 mRNA CTD PMID:30966736 troglitazone increases expression ISO RGD:10392 6480464 troglitazone results in increased expression of CPT2 mRNA CTD PMID:12732648 troglitazone increases expression ISO RGD:736835 6480464 troglitazone results in increased expression of CPT2 mRNA CTD PMID:27551952 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CPT2 mRNA, troglitazone results in increased expression of CPT2 protein CTD PMID:21315101 , PMID:21515302 valproic acid affects expression ISO RGD:736835 6480464 Valproic Acid affects the expression of CPT2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:736835 6480464 Valproic Acid results in decreased expression of CPT2 mRNA CTD PMID:29501571 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of CPT2 mRNA CTD PMID:23555832 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CPT2 mRNA CTD PMID:27225895 zaragozic acid A increases expression ISO RGD:10392 6480464 squalestatin 1 results in increased expression of CPT2 mRNA CTD PMID:27225895 zearalenone increases expression ISO RGD:10392 6480464 Zearalenone results in increased expression of CPT2 protein CTD PMID:25058043 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of CPT2 mRNA CTD PMID:15671213 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of CPT2 mRNA CTD PMID:15671213 zoledronic acid decreases expression ISO RGD:10392 6480464 zoledronic acid results in decreased expression of CPT2 mRNA CTD PMID:28871336 zoledronic acid multiple interactions ISO RGD:10392 6480464 Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of CPT2 mRNA], SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of CPT2 mRNA] CTD PMID:28871336